Connor, Clark & Lunn Investment Management (CC&L)’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.66M Buy
2024
Q2
Sell
2024
Q1
$132K Buy
2022
Q4
Sell
2022
Q3
$226K Buy